References
- WHO. Antimicrobial resistance. 2018 [cited 2020 Apr 7]. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
- Chaudhry D, Tomar P. Antimicrobial resistance: the next BIG pandemic. Int J Community Med Public Health. 2017;4(8):2632–2636.
- CDDEP. Antibiotic use and resistance in food animals: current policy and recommendations. center for disease dynamics, economics & policy (CDDEP). 2016 [cited 2020 May 8]. Available from:https://cddep.org/publications/antibiotic_use_and_resistance_food_animals_current_policy_and_recommendations/
- Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–1098.
- Kotwani A, Holloway K. Antibiotic prescribing practice for acute, uncomplicated respiratory tract infections in primary care settings in New Delhi, India. Trop Med Int Health TM IH. 2014;19(7):761–768.
- Kumar SG, Adithan C, Harish BN, et al. Antimicrobial resistance in India: a review. J Nat Sci Biol Med. 2013;4(2):286–291.
- Kotwani A, Holloway K. Trends in antibiotic use among outpatients in New Delhi, India. BMC Infect Dis. 2011;11(1):99.
- Tamhankar AJ, Karnik SS, Stålsby Lundborg C. Determinants of antibiotic consumption - development of a model using partial least squares regression based on data from India. Sci Rep. 2018;8(1):6421.
- Farooqui HH, Mehta A, Selvaraj S. Outpatient antibiotic prescription rate and pattern in the private sector in India: evidence from medical audit data. PLoS ONE. 2019;14(11):e0224848.
- Gandra S, Kotwani A. Need to improve availability of “access” group antibiotics and reduce the use of “watch” group antibiotics in India for optimum use of antibiotics to contain antimicrobial resistance. J Pharm Policy Pract. 2019;12(1):20.
- WHO. Adopt AWaRe:Handle antibiotics with care. AWaRe. [cited 2021 Mar 19]. Available from: https://adoptaware.org/
- Hsia Y, Lee BR, Versporten A, et al. Use of the WHO access, watch, and reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries. Lancet Glob Health. 2019;7(7):e861–71.
- Act against antibiotic abuse: India, world’s largest consumer of antibiotics, needs to step up. The Financial Express. 2020 [cited 2021 Apr 1]. Available from: https://www.financialexpress.com/opinion/act-against-antibiotic-abuse-india-worlds-largest-consumer-of-antibiotics-needs-to-step-up/2039297/
- Singh AK, Das S, Singh S, et al. prevalence of antibiotic resistance in commensal Escherichia coli among the children in rural hill communities of Northeast India. PLoS ONE. 2018;13(6):e0199179.
- Vadwai V, Nerurkar V, Kumari M, et al. Antimicrobial resistance pattern among community-acquired gram-positive and gram-negative bacterial bloodstream isolates in India. Ann Clin Lab Res. 2015;3(2):10.
- Mali NB, Deshpande SP, Karnik ND, et al. A multicentric, prospective, observational antibacterial utilization study in Indian tertiary referral centers. Indian. J Crit Care Med Peer-Rev Off Publ Indian Soc Crit Care Med. 2018;22(10):723–729.
- Founou RC, Founou LL, Essack SY. Clinical and economic impact of antibiotic resistance in developing countries: a systematic review and meta-analysis. PLoS ONE. 2017;12(12):e0189621.
- Laxminarayan R, Chaudhury RR. Antibiotic resistance in India: drivers and opportunities for action. PLoS Med. 2016;13(3):e1001974.
- McGettigan P, Roderick P, Kadam A, et al. Access, watch, and reserve antibiotics in India: challenges for WHO stewardship. Lancet Glob Health. 2017;5(11):e1075–6.
- Van Boeckel TP, Gandra S, Ashok A, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742–750.
- Kaul R Antibiotic intake in India rises by 30% in a decade, says report. Hindustan Times. 2021 [cited 2021 Mar 17]. Available from: https://www.hindustantimes.com/india-news/antibiotic-intake-in-india-rises-by-30-in-a-decade-says-report-101612377295525.html
- Klein EY, Van Boeckel TP, Martinez EM, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A. 2018;115(15):E3463–70.
- Farooqui HH, Selvaraj S, Mehta A, et al. Community level antibiotic utilization in India and its comparison vis-à-vis European countries: evidence from pharmaceutical sales data. PLoS ONE. 2018;13(10):e0204805.
- Laxminarayan R, Frost I What should India do to control antimicrobial resistance. 2020 [cited 2021 Mar 20]. Available from: https://www.downtoearth.org.in/blog/health/what-should-india-do-to-control-antimicrobial-resistance–74267
- Gandra S, Joshi J, Trett A, et al. Scoping report on antimicrobial resistance in India, center for disease dynamics, economics & policy. 2017 [cited 2021 Mar 21]. Available from: https://cddep.org/wp-content/uploads/2017/11/scoping-report-on-antimicrobial-resistance-in-india.pdf
- WHO. WHO report on Surveillance of antibiotic consumption: 2016–2018 early implementation. 2018. [cited 2020 April 21]. Available from: https://apps.who.int/iris/bitstream/handle/10665/277359/9789241514880-eng.pdf?ua=1
- Mordor Intelligence. Antibiotics Market Size, Growth Value, Overview (2020–2025). [cited 2021 Mar 21]. Available from: https://www.mordorintelligence.com/industry-reports/antibiotics-market
- Research AM. Antibiotics market to hit $40.78 billion by 2025 - global insights on top trends, growth drivers, competitive landscape, regulatory scenario and business opportunities: adroit market research. GlobeNewswire news room. 2020 [cited 2021 Mar 21]. Available from: https://www.globenewswire.com/news-release/2020/01/18/1972219/0/en/Antibiotics-Market-to-hit-40-78-Billion-by-2025-Global-Insights-on-Top-Trends-Growth-Drivers-Competitive-Landscape-Regulatory-Scenario-and-Business-Opportunities-Adroit-Market-Rese.html
- Das S Wockhardt becomes first Indian company to get nod for novel antibiotics. Business Standard India. 2020 [cited 2021 Mar 18]; Available from: https://www.business-standard.com/article/companies/wockhardt-becomes-first-indian-company-to-get-nod-for-novel-antibiotics-120011600612_1.html
- Ahmad A, Khan MU, Balkrishnan R. Fixed-dose combination antibiotics in India: global perspectives. Lancet Glob Health. 2016;4(8):e521.
- CDSCO. List Of Banned Drugs. 2018 [cited 2020 May 8]. Available from: https://cdsco.gov.in/opencms/opencms/en/consumer/List-Of-Banned-Drugs/index.html
- McGettigan P, Roderick P, Kadam A, et al. Threats to global antimicrobial resistance control: centrally approved and unapproved antibiotic formulations sold in India. Br J Clin Pharmacol. 2019;85(1):59–70.
- Reuters. India bans 328 combination drugs in setback for pharma companies. Reuters. 2018 [cited 2020 Apr 17]; Available from: https://www.reuters.com/article/us-india-health-drugs-idUSKCN1LT155
- Nair M, Tripathi S, Mazumdar S, et al. “Without antibiotics, I cannot treat”: a qualitative study of antibiotic use in paschim bardhaman district of West Bengal, India. PLoS ONE. 2019;14(6):e0219002.
- Agarwal M, Raghuwanshi SK, Asati DP. Antibiotic use in sore throat: are we judicious? Indian J Otolaryngol Head Neck Surg Off Publ Assoc Otolaryngol India. 2015;67(3):267–270.
- Chatterjee D, Sen S, Begum SA, et al. A questionnaire-based survey to ascertain the views of clinicians regarding rational use of antibiotics in teaching hospitals of Kolkata. Indian J Pharmacol. 2015;47(1):105.
- Sundin A Considerations for AMR in the Covid-19 pandemic. 2020 [cited 2020 Jun 3]. Available from: https://www.jpiamr.eu/considerations-for-antibiotic-resistance-in-the-covid-19-pandemic/
- Walia K How the coronavirus crisis may feed antimicrobial resistance. Hindustan Times. 2020 [cited 2020 Jun 3]. Available from: https://www.hindustantimes.com/analysis/how-the-coronavirus-crisis-may-feed-anti-microbial-resistance/story-v4jYF31vEA8lJZvi4PYSrI.html
- WHO. Record number of countries contribute data revealing disturbing rates of antimicrobial resistance. 2020 [cited 2020 Jun 3]. Available from: https://www.who.int/news-room/detail/01-06-2020-record-number-of-countries-contribute-data-revealing-disturbing-rates-of-antimicrobial-resistance
- Kotwani A, Chaudhury RR, Holloway K. Antibiotic-prescribing practices of primary care prescribers for acute diarrhea in New Delhi, India. Value Health J Int Soc PharmacoEcon Outcomes Res. 2012;15(1 Suppl):S116–119.
- Sandopa D, Nethi SK, Sreeram SC, et al. Prescribing antibiotics to pediatric dengue: increasing risk of bacterial resistance. Paediatr Indones. 2018;58(1):53–58.
- Martinez EP, Cepeda M, Jovanoska M, et al. Seasonality of antimicrobial resistance rates in respiratory bacteria: a systematic review and meta-analysis. PLoS ONE. 2019;14(8):e0221133.
- Setty NK, Nagaraja M, Nagappa D, et al. A study on Surgical Site Infections (SSI) and associated factors in a government tertiary care teaching hospital in Mysore, Karnataka. Int J Med Public Health. 2014;4(2):171.
- Negi V, Pal S, Juyal D, et al. bacteriological profile of surgical site infections and their antibiogram: a study from resource constrained rural setting of Uttarakhand state, India. J Clin Diagn Res JCDR. 2015 Oct;9(10):DC17–20.
- Pal S, Sayana A, Joshi A, et al. Staphylococcus aureus: a predominant cause of surgical site infections in a rural healthcare setup of Uttarakhand. J Fam Med Prim Care. 2019;8(11):3600–3606.
- Shah S, Singhal T, Naik R. A 4-year prospective study to determine the incidence and microbial etiology of surgical site infections at a private tertiary care hospital in Mumbai, India. Am J Infect Control. 2015;43(1):59–62.
- George CE, Norman G, Ramana GV, et al. Treatment of uncomplicated symptomatic urinary tract infections: resistance patterns and misuse of antibiotics. J Fam Med Prim Care. 2015;4(3):416–421.
- Taneja N, Sharma M. Antimicrobial resistance in the environment: the Indian scenario. Indian J Med Res. 2019;149(2):119–128.
- Okeke IN, Peeling RW, Goossens H, et al. Diagnostics as essential tools for containing antibacterial resistance. Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother. 2011;14(2):95–106.
- Kundu R. Rapid Diagnostic Tests in Childhood Infections. Indian Pediatr. 2018;55(3):233-237.
- ReAct Asia-Pacific. Antibiotic Use in Food Animals: India Overview. ReAct Asia-Pacific; 2018 [cited 2020 Aug 5]. Available from: https://www.reactgroup.org/wp-content/uploads/2018/11/Antibiotic_Use_in_Food_Animals_India_LIGHT_2018_web.pdf
- Ministry of agriculture and farmers welfare. State of Indian Agriculture 2015–16. Ministry of agriculture & farmers welfare department; 2016. Government of India. 2016 [cited 2020 May 5]. Available from: http://agricoop.nic.in/sites/default/files/State_of_Indian_Agriculture%2C2015-16.pdf
- Van Boeckel TP, Brower C, Gilbert M, et al. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci U S A. 2015;112(18):5649–5654.
- OECD. GLOBAL ANTIMICROBIAL USE IN THE LIVESTOCK SECTOR. Organisation for economic co-operation and development; 2015 [cited 2020 May 5]. Available from: https://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=TAD/CA/APM/WP(2014)34/FINAL&docLanguage=En
- Bhushan C, Khurana A, Sinha R, et al. Antibiotic resistance in poultry environment: spread of resistance from poultry farm to agricultural field. centre for science and environment;2017. [cited 2020 May 5]. Available from: http://www.indiaenvironmentportal.org.in/files/file/report-antibiotic-resistance-poultry-environment.pdf
- Kumar A, Gill JPS, Bedi JS, et al. Determination of antibiotic residues in Indian honeys and assessment of potential risks to consumers. J Apic Res 2020;59(1):25–34.
- Khullar S, Khurana. Too much too often: antibiotics in Indian crops can make them ineffective. 2019 [cited 2020 Jun 11]. Available from: https://www.downtoearth.org.in/news/agriculture/too-much-too-often-antibiotics-in-indian-crops-can-make-them-ineffective–67838
- Anjana RKNK, Jayachandran K. Persistence of Antibiotic Residue in Milk under Region of Bihar, India. Int J Curr Microbiol Appl Sci. 2017;6(3):2296–2299.
- Nilsson O. Vancomycin resistant enterococci in farm animals – occurrence and importance. Infect Ecol Epidemiol. 2012;2(2). DOI:https://doi.org/10.3402/iee.v2i0.16959
- Walia K, Madhumathi J, Veeraraghavan B, et al. Establishing antimicrobial resistance surveillance & research network in India: journey so far. Indian J Med Res. 2019;149(2):164–179.
- Brower CH, Mandal S, Hayer S, et al. The prevalence of extended-spectrum beta-lactamase-producing multidrug-resistant Escherichia coli in poultry chickens and variation according to farming practices in Punjab, India. Environ Health Perspect. 2017;125(7):077015.
- Bhattacharyya D, Banerjee J, Bandyopadhyay S, et al. First report on vancomycin-resistant staphylococcus aureus in bovine and caprine milk. Microb Drug Resist Larchmt N. 2016;22(8):675–681.
- Sudha S, Mridula C, Silvester R, et al. Prevalence and antibiotic resistance of pathogenic Vibrios in shellfishes from Cochin market. Indian J Geo-Mar Sci. 2014;43:815–824.
- CSE. FSSAI & BIS move to regulate antibiotics in honey. antibiotics in honey. center for science and environment. 2011 [cited 2020 May 5]. Available from: https://www.cseindia.org/fssai-bis-move-to-regulate-antibiotics-in-honey–4183
- FSSAI. Food Safety And Standards (Contaminants, Toxins And Residues) Regulations, 2011.Food safety and standards authority of india. 4th Ed, 2019;cited 2020 May 5 Available from https://www.coursehero.com/file/43162526/Compendium-Contaminants-Regulations-20-05-2019pdf/
- DAHD. NATIONAL LIVESTOCK POLICY, 2013. Ministry of agriculture department of animal husbandry, dairying & fisheries. government of India. 2013 [cited 2020 May 5]. Available from: http://dahd.nic.in/sites/default/filess/NLP%202013%20Final11.pdf
- ICAR. National action plan for anti-microbial resistance | Indian council of agricultural research. ministry of agriculture and farmers welfare. 2016 [cited 2020 May 5]. Available from: https://www.icar.org.in/node/6370
- McDougal T Indian government bans Colistin. PoultryWorld. [cited 2021 Apr 2]. Available from: https://www.poultryworld.net/Health/Articles/2019/8/Indian-government-bans-Colistin-457309E/
- Jamal WY, Albert MJ, Rotimi VO. High prevalence of New Delhi metallo-β-lactamase-1 (NDM-1) producers among carbapenem-resistant Enterobacteriaceae in kuwait. PloS One. 2016;11(3):e0152638.
- Mathew G, Unnikrishnan MK, Mathew G, et al. “The emerging environmental burden from pharmaceuticals”. Econ Political Weekly. 2012;47(18):31–34.
- Walsh TR, Weeks J, Livermore DM, et al. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis. 2011;11(5):355–362.
- WHO. GLASS | global antimicrobial resistance surveillance system (GLASS) report. WHO. World Health Organization; 2015 [cited 2020 May 5]. Available from: http://www.who.int/glass/resources/publications/early-implementation-report/en/
- Rameshkumar G, Ramakrishnan R, Shivkumar C, et al. Prevalence and antibacterial resistance patterns of extended-spectrum beta-lactamase producing Gram-negative bacteria isolated from ocular infections. Indian J Ophthalmol. 2016;64(4):303–311.
- Kapoor G, Saigal S, Elongavan A. Action and resistance mechanisms of antibiotics: a guide for clinicians. J Anaesthesiol Clin Pharmacol. 2017;33(3):300–305.
- Venkatesh S, Chauhan LS, Gadpayle AK et al. National treatment guidelines for antimicrobial use in infectious disease.national centre for disease control.directorate general of health services ministry of health & family welfare government of India. 2016;64. [cited 2020 May 5]. Available from: https://ncdc.gov.in/WriteReadData/l892s/File622.pdf
- Chatterjee N. Carbapenem resistance in Escherichia coli and Klebsiella pneumoniae among Indian and international patients in North India. Acta Microbiol Immunol Hung. 2019;66(3):367–376.
- Wei W-J, Yang H-F, Ye Y, et al. New delhi metallo-β-lactamase-mediated carbapenem resistance: origin, diagnosis, treatment and public health concern. Chin Med J (Engl). 2015 Jul 20;128(14):1969–1976.
- Pragasam AK, Shankar C, Veeraraghavan B, et al. Molecular mechanisms of colistin resistance in Klebsiella pneumoniae causing bacteremia from India—a first report. Front Microbiol. 2017;7:2135.
- Bandyopadhyay M, Chakraborty B, Kumar S, et al. A study on burden of carbapenem-resistant pseudomonas aeruginosa and Acinetobacter baumannii infections in a tertiary care hospital of eastern India. Int J Contemp Med Res IJCMR. 2019;6(12):L5–L13.
- Rodríguez-Baño J, Gutiérrez-Gutiérrez B, Machuca I, et al. Treatment of infections caused by extended-spectrum-beta-lactamase-, ampc-, and carbapenemase-producing enterobacteriaceae. Clin Microbiol Rev. 2018;31(2):e00079–17.
- Shankar C, Mathur P, Venkatesan M, et al. Rapidly disseminating blaOXA-232 carrying Klebsiella pneumoniae belonging to ST231 in India: multiple and varied mobile genetic elements. BMC Microbiol. 2019;19(1):137.
- Veeraraghavan B, Pragasam AK, Bakthavatchalam YD, et al. Newer β-Lactam/β-Lactamase inhibitor for multidrug-resistant gram-negative infections: challenges, implications and surveillance strategy for India. Indian J Med Microbiol. 2018;36(3):334.
- Kumar E, Usha K, Chaudhury A, et al. Detection of AmpC β-lactamases production in Acinetobacter species by inhibitor (disk) based & modified three dimensional (enzyme extraction) methods. Indian J Med Res. 2014;140(5):688–690.
- Odsbu I, Khedkar S, Khedkar U, et al. High proportions of multidrug-resistant Acinetobacter spp. isolates in a district in western India: a four-year antibiotic susceptibility study of clinical isolates. Int J Environ Res Public Health. 2018 19;15(1):153.
- Kulkarni AP, Nagvekar VC, Veeraraghavan B, et al. Current Perspectives on Treatment of Gram-Positive Infections in India: what Is the Way Forward? Interdiscip Perspect Infect Dis. 2019;2019:7601847.
- Purohit G, Gaind R, Dawar R, et al. Characterization of vancomycin resistant enterococci in hospitalized patients and role of gut colonization. J Clin Diagn Res JCDR. 2017;11(9):DC01–5.
- Rajan V, Prakash PH, Gopal S. Occurrence of linezolid-resistant Staphylococcus haemolyticus in two tertiary care hospitals in Mysuru, South India. J Glob Antimicrob Resist. 2017;8:140–141.
- Kapil A. Risk factors associated with MRSA infection in children. Indian Pediatr. 2015;52(1):22–24.
- WHO. WHO | global action plan on AMR. World Health Organization; 2015 [cited 2020 May 5]. Available from: http://www.who.int/antimicrobial-resistance/global-action-plan/en/
- WHO. WHO publishes list of bacteria for which new antibiotics are urgently needed. 2017 [cited 2021 Apr 3]. Available from: https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed
- Neill JO Tackling drug-resistant Infections Globally: final report and recommendations. The Review on Antimicrobial Resistance. 2016 [cited 2020 Sep 5]. Available from: https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf
- National Academies of Sciences E, Division H and M, Health B on G, Threats F on M. The Cost Dimensions of Antimicrobial Resistance. Understanding the Economics of Microbial Threats: Proceedings of a Workshop. National Academies Press (US), Washington (DC); 2018 [cited 2021 Mar 22]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534885/
- Dey S GDP on health: india’s health spend just over 1% of GDP - Times of India. 2018 [cited 2020 May 5]. Available from: https://timesofindia.indiatimes.com/business/india-business/indias-health-spend-just-over-1-of-gdp/articleshow/64655804.cms
- Atal S, Mathur A SB. Cost of Treating Bacterial Infections in India: a Cost Minimization Analysis to Assess Price Variations. Biomed Pharmacol J. 2020;13(2):765–778.
- Chandana. At 1.28% of GDP, India’s expenditure on health is still low although higher than before. 2019 [cited 2020 May 5]. Available from: https://theprint.in/health/at-1-28-gdp-india-expenditure-on-health-still-low-although-higher-than-before/313702/
- Dadgostar P. Antimicrobial Resistance: Implications and Costs. Infect Drug Resist. 2019;12:3903–3910.
- Sm B, Ja M, Le M, et al. Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Clin Microbiol Infect. 2017;23(1):48.e9–48.e16.
- Naylor NR, Atun R, Zhu N, et al. Estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrob Resist Infect Control. 2018;7(1):58.
- Vasudevan A, Memon BI, Mukhopadhyay A, et al. The costs of nosocomial resistant gram negative intensive care unit infections among patients with the systemic inflammatory response syndrome- a propensity matched case control study. Antimicrob Resist Infect Control. 2015;4(1):3.
- CDDEP. Global Antibiotic Resistance Partnership (GARP). Center for disease dynamics, economics & policy (CDDEP). 2009 [cited 2020 Jun 4]. Available from: https://cddep.org/projects/global-antibiotic-resistance-partnership/
- Ranjalkar J, Chandy SJ. India’s national action plan for antimicrobial resistance – an overview of the context, status, and way ahead. J Fam Med Prim Care. 2019;8(6):1828–1834.
- NAP. National Action Plan on Antimicrobial Resistance(NAP-AMR) 2017 – 2021. Ministry of health and family welfare. Government of India. 2017. [cited 2020 May 05]. Available from: https://ncdc.gov.in/WriteReadData/linkimages/AMR/File645.pdf
- Maya C Now, campaign to make Kerala’ antibiotic literate.’ The Hindu. 2019 Nov 18 [cited 2020 May 5]; Available from: https://www.thehindu.com/news/national/kerala/now-campaign-to-make-kerala-antibiotic-literate/article30001213.ece
- Sahni A, Bahl A, Martolia R, et al. Implementation of antimicrobial stewardship activities in India. Indian J Med Spec. 2020;11(1):5.
- Singh S, Charani E, Wattal C, et al. The state of education and training for antimicrobial stewardship programs in Indian hospitals―a qualitative and quantitative assessment. Antibiotics. 2019;8(1):11.